Feature Channels: Infectious Diseases

Filters close
Released: 1-Nov-2024 4:00 PM EDT
Houston Methodist Researchers Shed Light on Increased Rates of Severe Human Infections Caused by Streptococcus Subspecies
Houston Methodist

A concerning increase in global rates of severe invasive infections becoming resistant to key antibiotics has a team of infectious disease researchers at the Houston Methodist Research Institute studying a recently emerged strain of bacteria called Streptococcus dysgalactiae subspecies equisimilis (SDSE). SDSE infects humans via the skin, throat, gastrointestinal tract and female genital tract to cause infections ranging in severity from strep throat (pharyngitis) to necrotizing fasciitis (flesh-eating disease).

Released: 31-Oct-2024 3:45 PM EDT
In Memoriam: Diane Edmund Griffin, MD, PhD, 1940–2024
Johns Hopkins Bloomberg School of Public Health

Diane Griffin, MD, PhD, a pioneering infectious-disease virologist, scientific leader, and Johns Hopkins professor, died Monday. She was 84.

Released: 31-Oct-2024 12:20 PM EDT
New Findings on Animal Viruses with Potential to Infect Humans
Ohio State University

Scientists investigating animal viruses with potential to infect humans have identified a critical protein that could enable spillover of a family of organisms called arteriviruses.

Newswise: Advanced Modeling Contributes to Progress in Thwarting HIV in Sweden
Released: 30-Oct-2024 12:10 PM EDT
Advanced Modeling Contributes to Progress in Thwarting HIV in Sweden
Los Alamos National Laboratory

In a landmark achievement for the fight against HIV, Sweden has attained the critical “95-95-95” target on the path to tackling the disease. Advanced bioinformatics modeling developed by a team from Los Alamos National Laboratory was deployed to track and verify the country’s progress toward the Joint United Nations Programme on HIV/AIDS (UNAIDS) and World Health Organization target.

Released: 30-Oct-2024 12:00 PM EDT
Expert Available: Cases of Walking Pneumonia Are On The Rise
George Washington University

Mycoplasma pneumonia, commonly known as walking pneumonia, is spiking among kids in the U.S., according to the CDC. ...

Released: 30-Oct-2024 11:10 AM EDT
Wake Forest University School of Medicine and Atrium Health Awarded $2.5 Million in PCORI Funding to Improve Antibiotic Prescribing for Childhood Respiratory Infections
Wake Forest University School of Medicine

A team from Wake Forest University School of Medicine and Atrium Health has been approved for a $2.5 million funding award by the Patient-Centered Outcomes Research Institute (PCORI) to help improve antibiotic prescribing for children with acute respiratory tract infections in outpatient settings.

Newswise: Iowa State Study Shows Zinc’s Potential to Fight Antimicrobial Resistance
Released: 28-Oct-2024 3:55 PM EDT
Iowa State Study Shows Zinc’s Potential to Fight Antimicrobial Resistance
Iowa State University

A research team at Iowa State University has found that zinc supplements may be an inexpensive, effective antidote to the growing health threat of antimicrobial resistance, potentially extending the effectiveness of today’s antibiotic arsenal against disease.

   
Released: 28-Oct-2024 11:35 AM EDT
H5N1 Virus Isolated From Infected Dairy Worker Is 100% Lethal in Ferrets, but Does Not Appear to Be Circulating in Nature Anymore
University of Wisconsin–Madison

A strain of H5N1 avian influenza virus found in a Texas dairy worker who was infected this spring was able to spread among ferrets through the air, although inefficiently, and killed 100% of infected animals in studies University of Wisconsin–Madison researchers performed with the strain earlier this year.

Released: 24-Oct-2024 2:15 PM EDT
JMU Health Sciences Professor Remains a “Top 2% Scientist”
James Madison University

Sojib Zaman, a health sciences professor at James Madison University, has been listed for a third consecutive year in Stanford/Elsevier's Top 2% Scientist rankings.

Newswise: navbar-logo.png
18-Oct-2024 8:00 AM EDT
Según un nuevo estudio, el rechazo a las vacunas es menor entre las minorías
American College of Allergy, Asthma and Immunology (ACAAI)

Durante la pandemia de COVID, los medios informaron ampliamente que los pacientes negros tenían más probabilidades que los pacientes blancos de rechazar las vacunas, incluidas las vacunas contra la influenza y el COVID. Un nuevo estudio que se presentará en la Reunión Científica Anual del Colegio Americano de Alergia, Asma e Inmunología (ACAAI) de este año en Boston mostró que los pacientes que se identifican como no blancos tenían menos probabilidades de mostrar desconfianza en cuando a las vacunas que los pacientes que se identifican como blancos.

Newswise: victoraimagesized.jpg
Released: 23-Oct-2024 12:55 PM EDT
Surprising Reason That B Cells Benefit From Booster Shots
Rockefeller University

Certain infectious diseases, such as COVID or the flu, evolve constantly, shapeshifting just enough to outmaneuver our immune systems and reinfect us repeatedly. But subsequent reinfections often don’t lead to the most severe outcomes—for very good reason. Upon first exposure to a pathogen, our immune systems churn out specially trained B cells, which have learned to identify and eliminate the virus.

Newswise: shutterstock_mosquito-JP-edit.jpg
Released: 23-Oct-2024 12:45 PM EDT
West Nile Infections Are Spiking. Here’s Why the Percentage of Severe Cases Is So Small
Rockefeller University

The U.S. is currently in the midst of yet another West Nile virus (WNV) outbreak, with the CDC documenting 880 cases across 46 states so far this year.

Newswise: Novel Antibody Platform Tackles Viral Mutations
18-Oct-2024 11:15 AM EDT
Novel Antibody Platform Tackles Viral Mutations
Mount Sinai Health System

Scientists at the Icahn School of Medicine at Mount Sinai, in collaboration with colleagues in the field, have developed an innovative antibody platform aimed at tackling one of the greatest challenges in treating rapidly evolving viruses like SARS-CoV-2: their ability to mutate and evade existing vaccines and therapies. Their findings, including preclinical studies in mice, introduce the Adaptive Multi-Epitope Targeting and Avidity-Enhanced (AMETA) Nanobody Platform, a new antibody approach for addressing how viruses like SARS-CoV-2, which causes COVID-19, evolve to evade vaccines and treatments. Details on the results were published October 23 in the journal Cell.

Released: 22-Oct-2024 12:00 PM EDT
Insect Invasions: Why We Must Act Responsibly and Act Now
Universite de Montreal

Ecologist and academic Jacques Brodeur makes a compelling case for using biological pest control as a main line of defence against invasive non-native species.

Newswise: Yale School of Medicine Professors Elected to National Academy of Medicine
Released: 21-Oct-2024 12:05 PM EDT
Yale School of Medicine Professors Elected to National Academy of Medicine
Yale School of Medicine

Yale School of Medicine professors Erol Fikrig, MD, and Haifan Lin, PhD, have been elected to the National Academy of Medicine.

Newswise: 1920_vaccine-cedars-sinai.jpg?10000
Released: 21-Oct-2024 10:30 AM EDT
La Familia Que Se Vacuna Juntos, Se Mantienen Sanos Juntos
Cedars-Sinai

A medida que se acerca la temporada de gripe, los expertos en enfermedades infecciosas de Cedars-Sinai urgen a todos los miembros de la comunidad, desde los bebés en adelante, a vacunarse contra la gripe.



close
8.52608